BBVA
ONCY

Banco Bilbao Vizcaya Argentaria’s Oncolytics Biotech ONCY Stock Holding History

Banco Bilbao Vizcaya Argentaria’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-30,000
Closed -$56K – 735
2020
Q2 		$56K Hold
30,000
– – ﹤0.01% 744
2020
Q1 		$40K Buy
+30,000
New +$74.9K ﹤0.01% 669

Other funds holding ONCY

Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return
CIBC World Market
CIBC World Market Toronto, Ontario, Canada $61.3B AUM 39.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Comerica Bank
Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return

Banco Bilbao Vizcaya Argentaria's ONCY Position: Q3 2020 in Review

Banco Bilbao Vizcaya Argentaria sold out of Oncolytics Biotech (ONCY) in Q3 2020, closing a stake of 30,000 shares — an estimated $56K sold.

Banco Bilbao Vizcaya Argentaria first reported a position in ONCY in Q1 2020 and held it in 2 quarters. The position peaked at $56K in Q2 2020. 36 funds tracked by Wall St. Rank hold ONCY as of Q3 2020.

  • Banco Bilbao Vizcaya Argentaria reported no remaining Oncolytics Biotech position as of Q3 2020 after selling out during the quarter.
  • Banco Bilbao Vizcaya Argentaria sold 30,000 Oncolytics Biotech shares in Q3 2020, an estimated $56K.
  • Banco Bilbao Vizcaya Argentaria first reported a position in Oncolytics Biotech in Q1 2020 and held it in 2 quarters.
  • Banco Bilbao Vizcaya Argentaria's Oncolytics Biotech position peaked at $56K in Q2 2020.
  • 36 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q3 2020.

Based on Banco Bilbao Vizcaya Argentaria's 13F filing for Q3 2020, filed 12 Nov 2020.